DRAP1 antibody
Quick Overview for DRAP1 antibody (ABIN7880656)
Target
See all DRAP1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- DRAP1 Antibody
-
Purification
- Protein A/G affinity
-
Immunogen
- Recombinant human DRAP1 protein was used as the immunogen for the DRAP1 antibody.
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- Optimal dilution of the DRAP1 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the DRAP1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- DRAP1 (DR1-Associated Protein 1 (Negative Cofactor 2 Alpha) (DRAP1))
-
Alternative Name
- DRAP1
-
Background
- NC2 (negative cofactor 2) is a dimeric histone-fold complex that represses RNA polymerase II transcription through binding to TBP and inhibiting the transcription factors TFIIA and TFIIB. NC2 consists of two subunits, termed NC2a and NC2beta, and these subunits dimerize and bind to TBP-promoter complexes via histone fold domains of the H2A-H2B type. NC2 associates with promoters in a manner that correlates with transcriptional activity and with occupancy by basal transcription factors. NC2 binds directly to DNA, and the binding of NC2 to TBP-promoter complexes affects the conformation of DNA, and results in the inhibition of TFIIB.
-
UniProt
- Q14919
Target
-